ADMD, trading symbol, has disruptive technology for cancer diagnostics and therapeutic applications. For instance, our brachytherapy application, which is being put into the FDA for approval, may be the first to treat and cure pancreatic cancer. Secondly, our Mo-99 project may be able to sell to the USA healthcare network up to 50% of the necessary supply. See us at www.isotopeworld.com